Abstract
AbstractThe emergence of drug‐resistant strains of Neisseria gonorrhoeae poses a significant global health challenge, necessitating the development of novel antimicrobial agents. This study focuses on the potential of phenolic compounds to target the enzyme glyceraldehyde‐3‐phosphate dehydrogenase (GAPDH) in N. gonorrhoeae, a key protein involved in glycolysis and implicated in various pathological mechanisms. Among the compounds evaluated, quercetin demonstrated significant binding affinity to N. gonorrhoeae‐derived GAPDH. Structural integrity assessments using Procheck software and molecular docking simulations confirmed the binding capacity of quercetin. Molecular dynamics simulations further explored the stability and flexibility of the quercetin‐N. gonorrhoeae GAPDH complex. The results revealed interactions between quercetin and specific amino acid residues, suggesting potential binding sites crucial for antimicrobial action. This information provides valuable insights into the development of quercetin‐based therapeutics targeting drug‐resistant N. gonorrhoeae, addressing the urgent need for novel antimicrobial agents.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
